Your browser doesn't support javascript.
loading
Design of the VIALE-M phase III trial of venetoclax and oral azacitidine maintenance therapy in acute myeloid leukemia.
Ivanov, Vladimir; Yeh, Su-Peng; Mayer, Jiri; Saini, Lalit; Unal, Ali; Boyiadzis, Michael; Hoffman, David M; Kang, Kingston; Addo, Sadiya N; Mendes, Wellington L; Fathi, Amir T.
Affiliation
  • Ivanov V; Almazov National Medical Research Centre, Saint Petersburg, Russian Federation.
  • Yeh SP; China Medical University Hospital, Taichung City, Taiwan.
  • Mayer J; Fakultni Nemocnice Brno & Masaryk University, Brno, Czechia.
  • Saini L; London Health Sciences Center, ON, Canada.
  • Unal A; Erciyes University Medical School, Kayseri, Turkey.
  • Boyiadzis M; Genentech Inc., San Francisco, CA, USA.
  • Hoffman DM; AbbVie Inc., North Chicago, IL, USA.
  • Kang K; AbbVie Inc., North Chicago, IL, USA.
  • Addo SN; AbbVie Inc., North Chicago, IL, USA.
  • Mendes WL; AbbVie Inc., North Chicago, IL, USA.
  • Fathi AT; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Future Oncol ; 18(26): 2879-2889, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35852098
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Future Oncol Year: 2022 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: En Journal: Future Oncol Year: 2022 Document type: Article Country of publication: United kingdom